WallStreetZenWallStreetZen

NYSE: CTLT
Catalent Inc Stock

Open Broker Account
$45.54-1.68 (-3.56%)
Updated Dec 8, 2022
CTLT Price
$45.54
Fair Value Price
N/A
Market Cap
$8.20B
52 Week Low
$40.69
52 Week High
$130.97
P/E
19.38x
P/B
1.74x
P/S
2.7x
PEG
0.61x
Dividend Yield
N/A
Revenue
$4.83B
Earnings
$426.00M
Gross Margin
32.6%
Operating Margin
13.14%
Profit Margin
8.7%
Debt to Equity
1.17
Operating Cash Flow
$184M
Beta
1.13
Next Earnings
Jan 30, 2023
Ex-Dividend
N/A
Next Dividend
N/A

CTLT Overview

Catalent, Inc. provides manufactures branded drug products, biologics, gene therapies, and consumer health products. Catalent was formed in 2007 when affiliates of the Blackstone Group L.P. acquired the core of the pharmaceutical technologies and services segment of Cardinal Health, Inc. Catalent is headquartered in Somerset, NJ.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTLT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CTLT ($45.54) is trading above its intrinsic value of $41.63, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CTLT is good value based on its earnings relative to its share price (19.38x), compared to the US market average (21.39x)
P/E vs Market Valuation
CTLT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CTLT due diligence checks available for Premium users.

Be the first to know about important CTLT news, forecast changes, insider trades & much more!

CTLT News

Valuation

CTLT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
19.38x
Industry
19.44x
Market
21.39x
CTLT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CTLT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CTLT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.74x
Industry
1.76x
CTLT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CTLT price to earnings growth (PEG)

For valuing profitable companies with growth potential
CTLT is good value based... subscribe to Premium to read more.
PEG Value Valuation

CTLT's financial health

Profit margin

Revenue
$1.0B
Net Income
$0.0
Profit Margin
0%
CTLT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTLT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$10.2B
Liabilities
$5.5B
Debt to equity
1.17
CTLT's short-term assets ($2.70B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTLT's long-term liabilities ($4.56B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTLT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CTLT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$92.0M
Investing
-$116.0M
Financing
$74.0M
CTLT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CTLT vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
CTLT$8.20B-3.56%19.38x1.74x
RDY$8.94B+0.86%29.64x3.68x
TEVA$9.24B-1.54%-7.17x1.05x
ELAN$5.95B-0.16%-52.29x0.88x
PRGO$4.32B+1.61%-40.15x0.94x

Catalent Stock FAQ

What is Catalent's quote symbol?

NYSE: CTLT) Catalent trades on the NYSE under the ticker symbol CTLT. Catalent stock quotes can also be displayed as NYSE: CTLT.

If you're new to stock investing, here's how to buy Catalent stock.

What is the 52 week high and low for Catalent (NYSE: CTLT)?

(NYSE: CTLT) Catalent's 52-week high was $130.97, and its 52-week low was $40.69. It is currently -65.23% from its 52-week high and 11.92% from its 52-week low.

How much is Catalent stock worth today?

(NYSE: CTLT) Catalent currently has 179,963,589 outstanding shares. With Catalent stock trading at $45.54 per share, the total value of Catalent stock (market capitalization) is $8.20B.

Catalent stock was originally listed at a price of $19.99 in Jul 31, 2014. If you had invested in Catalent stock at $19.99, your return over the last 8 years would have been 127.81%, for an annualized return of 10.84% (not including any dividends or dividend reinvestments).

How much is Catalent's stock price per share?

(NYSE: CTLT) Catalent stock price per share is $45.54 today (as of Dec 8, 2022).

What is Catalent's Market Cap?

(NYSE: CTLT) Catalent's market cap is $8.20B, as of Dec 9, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Catalent's market cap is calculated by multiplying CTLT's current stock price of $45.54 by CTLT's total outstanding shares of 179,963,589.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.